U
NVO

UBS’s Novo Nordisk NVO Stock Holding History

UBS’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$23.9M Buy
1,002,186
+77,380
+8% +$1.78M 0.02% 854
2014
Q2 		$21.4M Buy
924,806
+12,386
+1% +$273K 0.02% 846
2014
Q1 		$20.8M Sell
912,420
-33,900
-4% -$722K 0.02% 773
2013
Q4 		$17.5M Sell
946,320
-167,590
-15% -$2.92M 0.02% 895
2013
Q3 		$18.9M Buy
1,113,910
+176,810
+19% +$2.97M 0.02% 743
2013
Q2 		$14.5M Buy
+937,100
New +$15.6M 0.02% 816

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

UBS's NVO Position: Q3 2014 in Review

UBS increased its Novo Nordisk (NVO) stake by 8.4% in Q3 2014, buying an estimated $1.78M and bringing the position to 1,002,186 shares worth $23.9M. The position accounts for 0.02% of the portfolio, ranked #854.

UBS first reported a position in NVO in Q2 2013 and has held it in 6 quarters since. 470 funds tracked by Wall St. Rank hold NVO as of Q3 2014.

  • UBS held 1,002,186 shares of Novo Nordisk worth $23.9M as of Q3 2014.
  • UBS bought 77,380 Novo Nordisk shares in Q3 2014, an estimated $1.78M.
  • Novo Nordisk made up 0.02% of UBS's portfolio in Q3 2014, its #854 holding.
  • UBS first reported a position in Novo Nordisk in Q2 2013 and has held it in 6 quarters since.
  • 470 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.